Literature DB >> 18754945

Clinical relevance of patients with epilepsy included in clinical trials.

Eva Tlusta, Kim B Handoko, Marian Majoie, Toine C G Egberts, Jiri Vlcek, Eibert R Heerdink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18754945     DOI： 10.1111/j.1528-1167.2008.01618_2.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  4 in total

1.  Natural variability in seizure frequency: Implications for trials and placebo.

Authors:  Juan Romero; Phil Larimer; Bernard Chang; Shira R Goldenholz; Daniel M Goldenholz
Journal:  Epilepsy Res       Date:  2020-03-06       Impact factor: 3.045

2.  Assessment of psychological distress in epilepsy: perspective from pakistan.

Authors:  Najam-Us Sahar
Journal:  Epilepsy Res Treat       Date:  2012-04-29

3.  Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.

Authors:  Vicente Villanueva; Martin Holtkamp; Norman Delanty; Juan Rodriguez-Uranga; Rob McMurray; Patricia Santagueda
Journal:  J Neurol       Date:  2017-09-18       Impact factor: 4.849

4.  PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice.

Authors:  Vicente Villanueva; Wendyl D'Souza; Hiroko Goji; Dong Wook Kim; Claudio Liguori; Rob McMurray; Imad Najm; Estevo Santamarina; Bernhard J Steinhoff; Pavel Vlasov; Tony Wu; Eugen Trinka
Journal:  J Neurol       Date:  2021-08-24       Impact factor: 4.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.